You also receive a $50 discount on your first month
The hypoglycemic strategy has also shifted from sugar control to both sugar control and heart protection
The end of PBMs is not exactly nigh, both because they are still so heavily involved in the sale of branded drugs and because operations like Cubans remain small relative to the size of the industry
Patient monitoring should include: Baseline lipid panel, hemoglobin A1c, and liver function tests Blood pressure monitoring (GLP-1 agents typically reduce systolic BP by 3-5 mmHg) [10] Assessment for gastrointestinal adverse effects during dose titration Evaluation for contraindications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2) [1] [3] Monitoring for gallbladder disease (increased risk with rapid weight loss) In patients with diabetes and retinopathy, monitoring for worsening eye symptoms, particularly with rapid glycemic improvement Renal function assessment, especially if severe gastrointestinal symptoms cause dehydration Patients should seek immediate medical attention for severe abdominal pain, which may indicate pancreatitisa rare but serious adverse effect
Several local providers have pharmaceutical research backgrounds, which means they approach GLP-1 prescribing from a clinical data perspective rather than a trends-and-marketing one
Check your Ozempic pen before you use it
